Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

Pfizer characterizes new antipsychotic agent

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Telomerase detection for bladder/prostatic cancer highlighted at AUA meeting

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...